Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2000; 35:292-299
© 2000 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Skyrme-Jones, R. A. P.
Right arrow Articles by Meredith, I. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Skyrme-Jones, R. A. P.
Right arrow Articles by Meredith, I. T.

Endothelial vasodilator function is related to low-density lipoprotein particle size and low-density lipoprotein vitamin E content in type 1 diabetes

R. Andrew P. Skyrme-Jones, BSc, MB, ChB*, Richard C. O’Brien, PhD{dagger}, Ming Luo, PhD{dagger} and Ian T. Meredith, MBBS, PhD, FACC*

* Centre for Heart and Chest Research, Monash Medical Centre and Monash University, Melbourne, Australia
{dagger} Department of Medicine, Monash Medical Centre and Monash University, Melbourne, Australia



View larger version (15K):

[in a new window]
 
Figure 1 Endothelium-dependent flow-mediated dilation (A) in diabetic (black bar) and control (white bar) subjects. FMD was significantly reduced in DM compared with control subjects (3.6 ± 0.6% vs. 7.1 ± 0.5%). Endothelium-independent GTN-induced vasodilation (B) was also reduced in DM compared with controls (15.4 ± 1.1% vs. 18.5 ± 0.8%), albeit to a lesser extent than FMD.

 


View larger version (23K):

[in a new window]
 
Figure 2 Relationship between flow-mediated dilation in diabetic (filled circles) and control (open circles) subjects with LDLPS. There was a significant correlation between FMD and LDLPS in the study cohort (A) and the diabetic group alone (B).

 


View larger version (23K):

[in a new window]
 
Figure 3 Relationship between flow-mediated dilation in diabetic (filled circles) and control (open circles) subjects with LDLVE. There was a significant correlation between FMD and LDLVE in the study cohort (A) and the diabetic group alone (B).

 


View larger version (18K):

[in a new window]
 
Figure 4 Absolute increase in forearm blood flow (A) and absolute reduction in forearm vascular resistance (B) in diabetic subjects (filled circles) and control subjects (open circles) during graded intraarterial infusion of acetylcholine (ACh). The changes in forearm blood flow and vascular resistance were attenuated in the diabetic group compared with the control group (p < 0.05).

 


View larger version (32K):

[in a new window]
 
Figure 5 (A and B) The relationship between the absolute change in forearm vascular resistance ({Delta}FVR) at peak dose of acetylcholine (ACh) and LDLPS (A) and LDLVE (B) in diabetic (filled circles) and control subjects (open circles). (C and D) The relationship between the slope of the {Delta}FVR ACh dose-response curve and LDLPS (C) and LDLVE (D).

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement